Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02997020 · ClinicalTrials.gov registry record
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis (EDSPD Protocol)
A clinical trial of CRS, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT02997020 is a study of CRS that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02997020, a study of CRS, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to establish the novel endoscopically-directed sinus potential difference (EDSPD) assay as an endpoint for therapy of sinus disease.
Conditions Studied
Interventions
- OTHER EDSPD
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-05-18 |
| Est. Completion | 2026-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02997020
The ClinicalTrials.gov registry entry for NCT02997020 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with CRS appearing as the primary indexed condition, and to 1 intervention - of which EDSPD is the first listed.
NCT02997020 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT02997020 about?
NCT02997020 is a clinical study titled "Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis (EDSPD Protocol)". The purpose of this study is to establish the novel endoscopically-directed sinus potential difference (EDSPD) assay as an endpoint for therapy of sinus disease.
What is the current status of trial NCT02997020?
This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2017-05-18. Estimated completion is 2026-04.
What conditions does trial NCT02997020 study?
This clinical trial studies the following conditions: CRS.
What interventions are being tested in trial NCT02997020?
The interventions under investigation include: EDSPD (OTHER).
Who is sponsoring clinical trial NCT02997020?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02997020 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.